Podcasts about professor gil mcvean

The Human Genome Project has been referred to as one of the great feats of scientific exploration and discovery in human history. But what was it, and, more to the point, what is the human genome and why was sequencing it such a big deal? And in 2020, some 17 years after it was deemed completed, what has it helped us with in the fields of biology and medicine, and what is there still to discover?Robin Ince is joined by three experts in the field. Geneticist, broadcast and author of a number of best selling books on the subject, Dr Adam Rutherford, one of the founders of the Human Cell Atlas Group and the Head of Cellular Genetics at the Wellcome Sanger Institute, Dr Sarah Teichmann and co-chair of the 1000 Genomes Project and founder of Genomics plc, Professor Gil McVean.To view previous episodes in the Genetics Shambles series head to Cosmicshambles.comFollow us on Twitter @GeneticsUnzip

In the final episode of our series, we’re looking back at the themes we’ve discussed so far, and forward into the likely development of AI. Professor Peter Millican will be joined by Professor Gil McVean, to further investigate how big data is transforming healthcare, by Dr Sandra Wachter, to discuss her recent work on the need for a legal framework around AI, and also by Professor Sir Nigel Shadbolt on where the field of artificial intelligence research has come from, and where it’s going. To conclude, Peter will be sharing some of his views on where humanity is heading with AI, when you’ll also hear from his final guest, Azeem Azhar, host of the Exponential View podcast. Futuremakers will be taking a short break now, but we’ll be back with series two in the new year, when we’ll be taking on another of society’s grand challenges: building a sustainable future. Before then we’ll also be publishing a special one-off episode on Quantum Computing and the global opportunities, and risks, it could present. To read more about some of the key themes in this episode, you can find Sandra Wachter’s recent papers below. - A Right to Reasonable Inferences: Re-Thinking Data Protection Law in the Age of Big Data and AI: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3248829 - Explaining Explanations in AI: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3278331 - Counterfactual explanations without opening the black box: automated decisions and the GDPR: https://jolt.law.harvard.edu/assets/articlePDFs/v31/Counterfactual-Explanations-without-Opening-the-Black-Box-Sandra-Wachter-et-al.pdf

Professor Gil McVean explains what Big Data is and how it can be used to better understand and treat complex conditions, such as heart disease and dementia.

Professor Gil McVean tells us how statistical genetics helps us understand and treat disease. Prof Gil McVean is the Head of Bioinformatics and Statistical Genetics at the Wellcome Trust Centre for Human Genetics. His research covers several areas in the analysis of genetic variation, combining the development of methods for analysing high throughput sequencing data, theoretical work and empirical analysis.

Professor Gil McVean tells us how statistical genetics helps us understand and treat disease. Prof Gil McVean is the Head of Bioinformatics and Statistical Genetics at the Wellcome Trust Centre for Human Genetics. His research covers several areas in the analysis of genetic variation, combining the development of methods for analysing high throughput sequencing data, theoretical work and empirical analysis.

Professor Gil McVean tells us how statistical genetics helps us understand and treat disease. Genomic technology and statistical analysis of the genome is a powerful tool in understanding disease. Prof Gil McVean is the Head of Bioinformatics and Statistical Genetics at the Wellcome Trust Centre for Human Genetics. Professor McVean's research covers several areas in the analysis of genetic variation. Combining the development of methods for analysing high throughput sequencing data, theoretical work, and empirical analysis, this research may lead to genetic diagnosis and targeted treatments for disease.

Professor Gil McVean tells us how statistical genetics helps us understand and treat disease. Genomic technology and statistical analysis of the genome is a powerful tool in understanding disease. Prof Gil McVean is the Head of Bioinformatics and Statistical Genetics at the Wellcome Trust Centre for Human Genetics. Professor McVean's research covers several areas in the analysis of genetic variation. Combining the development of methods for analysing high throughput sequencing data, theoretical work, and empirical analysis, this research may lead to genetic diagnosis and targeted treatments for disease.